African American Participation in AD Research: Effective Strategies Workshop
Tuesday, October 9, 2018, 4:00 – 5:00 pm
13th Annual Norman R. Seay Lecture
Reception to follow
Wednesday, October 10, 2018, 8:00 am – 5:00 pm
African American Participation in AD Research: Effective Strategies
Location: Eric P. Newman Education Center on the campus of Washington University School of Medicine,
Saint Louis, Missouri, 63110
Tuesday, October 9, 13th Annual Norman R. Seay Lecture
The Seay Lecture is named after Mr. Norman R. Seay, a recognized civil rights leader both nationally and in his home town of Saint Louis. It is the first lecture named for an African American at the Washington University School of Medicine. Dr. John C. Morris inaugurated the annual Norman R. Seay Lecture in 2006 when Mr. Seay stepped down as the inaugural chair of the Knight ADRC African American Advisory Board, though he remains an active member of the board. In its 13th year, the Seay lecture serves as an important platform to educate both the academic and lay communities about research relevant to African Americans and Alzheimer disease.
In 2018, we will have two Seay Lecturers. Joyce Balls-Berry, PhD, Assistant Professor of Epidemiology at Mayo Clinic, is a psychiatric epidemiologist and health educator. Her primary research focus is evaluating the application of community-engaged research principles in diverse populations. Carl Hill, PhD, MPH, Director of the Office of Special Populations at the National Institute on Aging, is a leading advocate for efforts to address health disparities in biomedical research and its workforce.
A reception will follow the keynote presentation.
Wednesday, October 10, 2018, African American Participation in AD Research: Effective Strategies
By 2050, over 40% of older adults will be minorities. As the aging United States population becomes increasingly diverse, the lack of information from diverse populations has potentially critical clinical considerations. Participation in Alzheimer disease (AD) research programs is overwhelmingly by non-Hispanic white persons. As a result, relatively little is known about Alzheimer disease and related disorders in persons from under-represented groups. This presents an enormous missed opportunity to fully appreciate the relevance of AD across all people. Join us to examine critical issues surrounding recruitment of African American participants into research studies, so that the benefit of future AD treatments and interventions will be a reality for everyone.
There is no fee to attend this workshop. Funding is provided by the National Institute on Aging grant R13AG059415. A full schedule will be available in early summer.
Session 1: Rationale for Including African Americans in Alzheimer Disease (AD) Research
Topic A: Overview of Racial Differences in AD
Topic B: Epidemiological Perspectives
Topic C: Clinical Perspectives
Topic D: Genetic Perspectives
Topic E: Molecular Biomarker Perspectives
Session 2: Barriers to African American Research Participation
Session 3: “Best Practices” for African American Research Participation
Topic A: Longitudinal clinical and autopsy studies
Topic B: Biomarker studies
Session 4: Improving the Diversity of ADC Faculty and Staff
Session 5: Evidence-based Strategies to Improve African American Recruitment
John C. Morris, MD, Washington University
Carl Hill, PhD, MPH, National Institute on Aging
Consuelo H. Wilkins, MD, MSCI, Vanderbilt-Meharry Alliance
Crystal Glover, PhD, Rush University
Douglass Petty, PhD, Washington University African American Advisory Board
Goldie S. Byrd, PhD, North Carolina A&T University
Hugh Hendrie, MB, ChB, DSc, Indiana University
Jennifer Manly, PhD, Columbia University
Lisa Barnes, PhD, Rush University
Nancy Morrow-Howell, PhD, MSW, Washington University
Rachel Whitmer, PhD, Kaiser Permanente
William Hu, MD, PhD, Emory University
For information regarding this event, contact Jennifer Phillips at 314-286-2882 or email@example.com